Used Zimmer Biomet NexGen for Sale in Illinois
Chicago orthopedic surgeons run Zimmer Biomet NexGen as a flexible total knee system choice across the metro's varied joint replacement settings. Illinois prices run about 8% above baseline.
Illinois units run 8% above baseline: $2,160–$5,940.
Zimmer Biomet NexGen - Key specifications
- Total knee replacement system
- LPS and CR options
Pricing in Illinois
Zimmer Biomet NexGen vs alternatives
| Model | Brand | Used Price | Key Spec |
|---|---|---|---|
| Zimmer Biomet NexGen ✓ | Zimmer Biomet | $2,000–$5,500 | Total knee replacement system, LPS and CR opt... |
| OEC 9900 Elite | GE Healthcare | $30,000–$70,000 | C-arm fluoroscopy, 9-inch II, mobile... |
| Cios Select | Siemens | $25,000–$55,000 | C-arm, flat panel, carbon fiber table... |
| Vision R Iso-C | Ziehm | $22,000–$50,000 | Mobile C-arm, isocentric, 3D... |
Active buyers in Illinois
Facilities in Illinois currently using or sourcing Zimmer Biomet NexGen:
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
- University of Chicago Medical Center, Chicago
- Advocate Christ Medical Center, Oak Lawn
- OSF Saint Francis Medical Center, Peoria
Clinical experts on Zimmer Biomet NexGen
- Dr. Kevin Wilk - ASMI Birmingham. isokinetic testing and rehabilitation equipment specialist.
FAQ - Zimmer Biomet NexGen in Illinois
Is Zimmer Biomet NexGen a common choice for Chicago's joint replacement centers?
Yes - its established reliability and flexible design options make it a frequently chosen total knee system across Chicago joint replacement centers.
What is the price of used Zimmer Biomet NexGen in Illinois?
Illinois units run 8% above baseline: $2,160–$5,940. Price depends on hours, condition grade, and included accessories.
Does TechCosmetic ship Zimmer Biomet NexGen to Illinois?
Yes. We ship to all 50 states including Illinois. Freight quotes within 24 hours, coordinated with local riggers in major Illinois cities.
More on Zimmer Biomet NexGen
Similar equipment
Zero buyer commission · 2-hour response